Meeting
Abstract Number: I5
SHM Converge 2022
Background: Hospitalists often care for patients who have substance use disorders as well as patients who are incarcerated. Availability of medications for substance use disorders (MSUD) varies based on state law and access varies based on facility, city, and county. Since hospitalization presents a unique opportunity to prevent negative consequences of substance use disorders, it […]
Abstract Number: J6
SHM Converge 2022
Background: Prior studies have found Black and Hispanic patients are more likely to experience disparities in pain management. Fewer studies have evaluated pain control based on age, sex, body mass index (BMI), or presence of a substance use disorder (SUD). While factors influencing management of acute pain are complex, striving for adequate pain control remains […]
Abstract Number: F18
SHM Converge 2022
Background: In utero opioid exposure can result in neonatal abstinence syndrome (NAS). NAS is a serious condition characterized by central nervous system hyperirritability and autonomic nervous system and gastrointestinal tract dysfunction. Newborns with NAS may require pharmacological management, have increased hospital costs, and have a prolonged hospital length of stay (LOS). NAS incidence has increased […]